DOI:10.29111/ijlrst ISRA Impact Factor:3.35, Peer-reviewed, Open-access Journal
Research Paper Open Access
International Journal of Latest Research in Science and Technology Vol.6 Issue 5, pp 60-66,Year 2017
Correspondence should be addressed to :
Received : 20 October 2017; Accepted : 28 October 2017 ; Published : 14 November 2017
Download | 125 |
---|---|
View | 183 |
Article No. | 10760 |
The alarming rate of the increase in multidrug-resistant cases of Pseudomonas aeruginosa is a growing clinical issue necessitating the urgent need for new antibiotics and alternative strategies to combat the bacterial pathogen. Repurposing approved drugs in clinical use with known pharmacology and toxicology is one such cost-effective alternative approach. In this study, four essential protein targents for P. aeruginosa involved in the development of multidrug resistance were selected from Protein Data Bank using a validated method. Structure-based virtual screening method with PyRx was used to screen a database of 175 approved drugs. Celecoxib and meloxicam (marketed inhibitors of cyclooxygenase-2), fluconazole (an antifungal), desloratadine (antihistamine) and nitrofurantoin were found to bind with all the protein targets with binding energy greater than that obtained with the respective cocrystallized ligands.
Copyright © 2017 Adamu et al. This is an open access article distributed under the Creative Commons Attribution 4.0 International (CC BY 4.0) license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Adamu, Ahmed Adamu,Bello, shaibu Oricha,Chika, Aminu , " Evaluation Of Some Generic Drugs For Reversal Of Multidrug-resistance In Pseudomonas Aeruginosa Using Computer-aided Drug Design ", International Journal of Latest Research in Science and Technology . Vol. 6, Issue 5, pp 60-66 , 2017
MNK Publication was founded in 2012 to upholder revolutionary ideas that would advance the research and practice of business and management. Today, we comply with to advance fresh thinking in latest scientific fields where we think we can make a real difference and growth now also including medical and social care, education,management and engineering.
We offers several opportunities for partnership and tie-up with individual, corporate and organizational level. We are working on the open access platform. Editors, authors, readers, librarians and conference organizer can work together. We are giving open opportunities to all. Our team is always willing to work and collaborate to promote open access publication.
Our Journals provide one of the strongest International open access platform for research communities. Our conference proceeding services provide conference organizers a privileged platform for publishing extended conference papers as journal publications. It is deliberated to disseminate scientific research and to establish long term International collaborations and partnerships with academic communities and conference organizers.